Substituted nitrogen containing compounds
AssigneeBristol-Myers Squibb Company
InventorsNavnath Dnyanoba Yadav, Rajeev S. Bhide, Rajesh Onkardas Bora, Prashantha Gunaga, Manoranjan Panda, Eldon Scott Priestley, Jeremy Richter
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of Formula (I) or a salt thereof, wherein R1 is: each W is independently NR1b or O; Z is a bond or CHR1d; and R1, R2, Rd, R3a, R3b, L1, B, V, Y, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of ROMK, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating cardiovascular diseases.
Claims61
A compound having the structure of Formula (I)
- or a salt thereof, wherein:
- R1 is:
- each W is independently NR1b or O;
- Z is a bond or CHR1d;
- X is independently N or CR1a, wherein X is N at only 0, 1, or 2 positions;
- each R1a is independently H, F, Cl, —OH, —CN, C1-3 alkyl, C1-3 fluoroalkyl, C3-6 cycloalkyl, C1-3 alkoxy, or C1-3 fluoroalkoxy;
- each R1b is independently H, C1-3 alkyl, C2-3 fluoroalkyl, C3-6 cycloalkyl
- R1c is independently H, deuterium, C1-4 alkyl, C1-4 fluoroalkyl, or C3-6 cycloalkyl;
- R1d is H, C1-3 alkyl, C1-4 fluoroalkyl, or C3-6 cycloalkyl;
- Y is —C(R6)2—, —C(R6)2—C(R6)2—, —C(O)—, —C(O)—C(R6)2—, —C(R6)2—C(O)—, or SO2—;
- V is —O—, —NR4—, —CR5R5—, —S—, —S(O)—, —SO2—, or —C(O)—;
- wherein if V is —O—, —S—, —S(O)—, —SO2—, or —C(O)—, then Y is not —SO2—, and wherein if V is —O—, —S—, or NR4, then Y is not C(R6)2, and wherein if V is —S(O)—, —SO2—, or C(═O)—, then Y is not —C(═O)—, —C(═O)—C(R6)2—;
- L1 is —C(R)2—, —C(O)—, or —C(R)2—C(R)2—;
- wherein R is independently H, F, OH, C1-3 alkyl, C1-3 hydroxyalkyl, C1-3 alkoxyalkyl, or C1-3 fluoroalkyl;
- wherein R is not —OH or F if it is attached to a carbon atom that is adjacent to a nitrogen atom:
- Ring B is phenyl, pyridinyl, pyrimidinyl, pyrrazolyl, thiazolyl, imidazolyl, triazolyl, tetrazolyl, oxadiazolyl, thiadiazolyl, isoxazolyl, isothiazolyl, pyrrolyl, pyrazinyl, oxazolyl, pyridazinyl, pyrrolidinyl, or imidazolidinyl;
- R2 is a C6-10 aryl, or a 5 to 10 membered heterocycle ring containing 1 to 4 heteroatoms selected from N, O, and S, the heterocycle ring optionally containing an oxo substitution, the aryl or heterocycle ring are substituted with 0-3 R2a;
- R2a is independently OH, ═O, CN, halo, C1-4 alkyl, C1-4 deuteroalkyl, C1-4 fluoroalkyl, C1-4 alkoxy, C1-4 deuteroalkoxy, C1-4 fluoroalkoxy, C3-6 cycloalkyl, C3-6 cycloalkoxy, C(═O)NR4bR4b, C(═O)C1-4 alkyl, SO2Re, NR4bSO2R4b, or a 4 to 6 membered heterocycle having 1, 2, 3, or 4 heteroatoms selected from O, S, and N, the heterocycle optionally containing an oxo substitution and is substituted with 0-3 R2b;
- R2b is independently C1-3 alkyl, C1-3 fluoralkyl, C1-3 hydroxyalkyl, C3-6 cycloalkyl, or C3-6 fluorocycloalkyl;
- R3a is H, halo, OH, CN, C1-3 alkyl, C1-3 hydroxyalkyl, C1-3 fluoroalkyl, C1-3 alkoxy, or C3-6 cycloalkyl, wherein if V is —O—, —NR4—, —S—, —S(O)—, —SO2—, or —C(═O)—, then R3a is not halo, and wherein if V is —O—, —NR4—, —S—, then R3a is not OH, CN;
- R3b is H, ═O, C1-3 alkyl, C1-3 hydroxyalkyl, C1-3 fluoroalkyl, C1-3 alkoxy, or C3-6 cycloalkyl;
- R4 is H, C1-3 alkyl, C2-3 fluoroalkyl, C2-3 hydroxyalkyl, CO2R4a, C(O)R4a, SO2R4a, C(O)N(R4bR4b), SO2N(R4bR4b), or OH;
- R4a is C1-3 alkyl, C1-3 fluoroalkyl, C3-6 cycloalkyl, C3-6 fluorocycloalkyl, C6-10 aryl or a 4 to 10 membered heterocycle having 1, 2, 3 or 4 heteroatoms selected from O, S, and N, the aryl or heterocycle being substituted with 0-3 R4c;
- R4b is independently H, C1-3 alkyl, C2-3 fluoroalkyl, C3-6 cycloalkyl, C3-6 fluorocycloalkyl, C6-10 aryl or a 4 to 10 membered heterocycle having 1, 2, 3 or 4 heteroatoms selected from O, S, and N;
- alternatively, 2 R4bs, along with the atom to which they are attached, join to form a 3 to 6 membered saturated ring containing an additional 0-2 heteroatoms selected from O, S, and N;
- R4c is independently H, F, Cl, or C1-3 alkyl;
- R5 is independently H, F, OH, C1-3 alkoxy, C1-3 fluoroalkoxy, C1-3 alkyl, C1-3 fluoroalkyl, C1-3 hydroxyalkyl, C3-6 cycloalkyl, C3-6 fluorocycloalkyl, NR5bR5b, O—R5c, or 2 R5s are ═O;
- wherein if one R5 is F, OH or NR5bR5b, then the other R5 is not OH, or NR5bR5b;
- R5b is independently H, C1-3 alkyl, C3-6 cycloalkyl, C(O)Ra, SO2Ra, or C(O)NRbRb;
- alternatively, 2 R5bs, along with the atom to which they are attached, join to form a 3 to 6 membered saturated ring containing 0-2 heteroatoms selected from O, S, or N;
- R5c is independently H, C1-3 alkyl, C3-6 cycloalkyl, or C(O)NRbRb;
- R6 is independently H, OH, F, C1-3 alkyl, C1-3 deuteroalkyl, C1-3 fluoroalkyl, C3-6 cycloalkyl, C3-6 fluorocycloalkyl, C1-3 alkoxy, C1-3 hydroxyalkyl, C1-3 hydroxydeuteroalkyl, C1-3 alkoxyalkyl, or C1-3 fluoroalkoxyalkyl, or NR6bR6b;
- wherein if one R6 on one carbon atom is F, OH or NR6bR6b, then the other R6 on the same carbon atom is not OH or NR6bR6b;
- R6b is independently H, C1-3 alkyl, C3-6 cycloalkyl, C(O)Ra, SO2Ra, or C(O)NRbRb;
- alternatively, 2 R6s along with the same atom to which they are attached can form a 3 to 6 membered saturated ring containing 0-2 heteroatoms selected from O, S, and N;
- Ra is independently H, C1-3 alkyl, C2-3 fluoroalkyl, C3-6 cycloalkyl, C3-6 fluorocycloalkyl, C6-10 aryl or a 4 to 10 membered heterocycle having 1, 2, 3, or 4 heteroatoms selected from O, S, and N;
- Rb is independently H, C1-3 alkyl, C2-3 fluoroalkyl, C3-6 cycloalkyl, C3-6 fluorocycloalkyl, C6-10 aryl or a 4 to 10 membered heterocycle having 1, 2, 3 or 4 heteroatoms selected from O, S, and N;
- alternatively, 2 Rb's along with the atom to which they are attached, join to form a 3 to 6 membered saturated ring, containing 0-2 heteroatoms selected from O, S, and N;
- each Rd is independently H, F, C1-3 alkyl, C1-3 fluoroalkyl, C1-3 alkoxy, C1-3 fluoroalkoxy, C1-3 hydroxyalkyl, C3-6 cycloalkyl, halo, OH, ═O, CN, OCF3, OCHF2, CHF2CF3, or C(O)NReRe;
- each Re is independently H, C1-3 alkyl, C2-3 fluoroalkyl, C3-6 cycloalkyl, C2-3 hydroxyalkyl, C2-3 alkoxyalkyl, C6-10 aryl, or a 5 to 10 membered heteroaryl having 1, 2, 3, or 4 heteroatoms selected from O, S, and N;
- alternatively, 2 Res along with the atom to which they are attached, join to form a 3 to 6 membered saturated ring, containing 0-2 heteroatoms selected from O, S, or N;
- and
- n is 0, 1, or 2.
A compound, wherein the compound is
- or salt thereof.
A compound, wherein the compound is
A compound, wherein the compound is
- or salt thereof.
A compound, wherein the compound is
A compound, wherein the compound is
- or salt thereof.
A compound, wherein the compound is
A compound, wherein the compound is
- or salt thereof.
A compound, wherein the compound is
A compound, wherein the compound is
- or salt thereof.
A compound, wherein the compound is
A compound, wherein the compound is
- or salt thereof.
A compound, wherein the compound is
Dependencies are inferred from the claim text.